Tirzepatide
Tirzepatide – Research Grade Peptide
Tirzepatide is a synthetic peptide supplied exclusively for laboratory research and analytical purposes. It is a dual receptor agonist currently under scientific investigation for its interaction with metabolic and hormonal signalling pathways.
Tirzepatide is classified as an unlicensed investigational compound in this context and has not been authorised for use as a medicinal product in the United Kingdom by the Medicines and Healthcare products Regulatory Agency (MHRA) when supplied for research purposes.
Research Context
Tirzepatide is commonly studied in relation to:
Glucose-dependent insulinotropic polypeptide (GIP) receptor activity
Glucagon-like peptide-1 (GLP-1) receptor interactions
Metabolic and endocrine pathway research
These areas remain under ongoing scientific investigation. Any references are provided for informational purposes only and do not represent established clinical outcomes.
Intended Use
For in vitro research use only
Not for human or veterinary use
Not intended for medicinal, diagnostic, or therapeutic purposes
This product must only be handled by qualified professionals within appropriate laboratory environments.
Regulatory Compliance
This product is not a licensed medicine and must not be marketed, sold, or used as such. It is supplied strictly on the condition that it will be used for legitimate research purposes only.
Disclaimer
All information provided is for educational and scientific purposes only. No claims are made regarding safety, efficacy, or suitability for any medical application. The supplier does not promote or condone use outside of controlled research settings.
